Industry & Commerce

A collection of best practices in public health

Thursday, November 10, 2016 - 08:58

The exploration and adoption of best practices in health by public institutions and non-governmental organizations as well has been growing in recent years. ASSET experts recognize the importance of these activities. Thus, they will gather examples from all around Europe and present them on a dedicated page.

But what exactly are “best practices”, and what are the differences between best and good practices?

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Citizens' Mobilization, Gender, Human Rights, Local Activities, Policy, Stakeholders
Tags: 
best practice, science-in-society

Too long time for a new vaccine in case of an emerging infectious threat

November 9, 2016

In 2009 A(H1N1) pandemic, vaccines were ready and could be supplied only when the peak of the pandemic was already decreasing in most European countries, discouraging people from getting vaccinated. Since the disease was not as severe as it was feared in the beginning, the consequences of this delay were not that serious, even if some lives could have been saved if the vaccines were available in advance. Ebola vaccine also arrived to West Africa when the epidemic was over, while a zika vaccine is still very far away. According to Thomas Breuer, however, GSK Chief Medical Officer, in case of another flu pandemic, a better cooperation among stakeholders and new technologies could accelerate the production and supply of new vaccines.

Target: 
Government and Public Health, Healthcare Professionals, Industry & Commerce
Topic: 
Stakeholders, Vaccination
Tags: 
Video, H1N1, pandemic, flu, influenza, swine flu, Ebola, zika, Vaccine

MycoSynVac: synthetic biology, paying attention to ethical issues

Thursday, September 22, 2016 - 09:11

Vaccines have had broad medical impact, but existing vaccine technologies and production methods are limited in their ability to respond to certain pathogens. Other hurdles are due to difficulties in large scale production. MycoSynVac project proposes a new way for developing vaccines, by using of cutting-edge synthetic biology methodologies to engineer Mycoplasma pneumoniae as a universal chassis for vaccination.

Target: 
Industry & Commerce
Topic: 
Microbiology, Stakeholders, Vaccination
Tags: 
Vaccine, ethics, synthetic biology

TeamVax Italy and the Italian Charter for the promotion of immunization

Friday, September 16, 2016 - 10:32

Parents, healthcare workers, bloggers and science communicators have launched a positive experience in Italy, with the aim of sharing and promoting scientific information towards an important public health goal: to face the drop in vaccine coverage.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Citizens' Mobilization, Human Rights, Local Activities, Prevention, Social Media, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, engagement, science-in-society

Public Engagement in Research, Practice and Policy

Wednesday, November 16, 2016 (All day)

Public engagement that sets citizens and stakeholders as co-designers and collaborators of R&I activities can contribute to more dynamic and responsible governance of research and innovation. Public Engagement for Research, Practice and Policy conference, to be organized on November 16-17 in Brussels, calls for experts, stakeholders, policy-makers, entrepreneurs, researchers, regional authorities and Commission officials to a joint discussion on this theme.

Read more
Type: 
General event
Target: 
Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce
Topic: 
Local Activities, Policy, Stakeholders
Tags: 
Event, best practice, engagement, innovation

WHO and industry: agreements in case of pandemic

June 13, 2016

One of the main source of distrust towards public health authorities is the suspect of hidden connections with the pharmaceutical industry, but, in case of a severe pandemic, an adequate supply of antivirals and vaccines is essential. ASSET asked Norman Begg, GSK Vice President, Head of Scientific Affairs and Public Health, Vaccines, what kind of agreements exist for Public Health Emergencies of International Concern (PHEIC) or of a pandemic, between big pharma and WHO. The answer for the two situations is not the same.

Target: 
Government and Public Health, Industry & Commerce
Topic: 
Stakeholders, Vaccination
Tags: 
WHO, Vaccine, Video

Vaccines: a case history of false balance on TV

Monday, May 23, 2016 - 11:09

Until the end, it seemed it could sort out to be a happy-ending story, a demonstration of how new social networks, renown for spreading misinformation, can also correct it, when used properly. But the unfortunately predictable finale showed the opposite: counteracting false ideas about vaccines is not that easy. It will take time, a big deal of patience, communication skills and a good, coordinated strategy as well.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Media, Social Media, Stakeholders, Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Vaccine safety, Social media, false balance

RRI: a different idea of responsibility

Friday, May 20, 2016 - 10:14

It is never easy to develop definitions, especially when we are talking about something that is emerging and changing as we speak. This is the case for Responsible Research and Innovation (RRI), an emerging process within European Framework Programs whose definition is new and evolving. However, we can certainly identify a number of key characteristics of RRI, which is an umbrella term including a wide variety of notions, coming from the academia and politics.

Target: 
Decision Makers, Government and Public Health, Industry & Commerce
Topic: 
Stakeholders
Tags: 
research, innovation

Cooperation and engagement for a polio-free world

Friday, May 6, 2016 - 11:11

“We are so close to ending the polio” and “Still 15 years to a polio-free world” are not contradictory statements. They instead describe, with different degree of optimism, the current framework and the objective to be pursued in the fight against this disease. In other words, we are closer than ever to the target of a world free of polio, but much remains to be done to carry the world across the threshold. Polio eradication is the next issue public health authorities will be committed to in midterm future.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Topic: 
Epidemiology, Media, Microbiology, Prevention, Stakeholders, Vaccination
Tags: 
polio, Vaccine, Vaccine safety, Surveillance, engagement, ECDC

ASSET project: just in case

January 18, 2016

The European Union's Seventh Framework Programme for research cofunds ASSET project, a resource in case of infectious threats.
ASSET project provides public health authorities with resources, suggestions and tools that could help to draw and review pandemic and epidemic preparedness plans, both national and transnational - introducing Science-in-Society issues, such as those related to ethics and gender.
It makes available a qualified and diverse network of experts in disaster management, public health and risk communication.
A bridge between stakeholders, public health authorities and general public, also through social media in order to encourage listening, improve dialogue, facilitate mutual learning and enhance mobilization.
Just in case.

Target: 
Citizens, Decision Makers, Government and Public Health, Healthcare Professionals, Industry & Commerce, School and Education
Tags: 
Video

Pages

Subscribe to Industry & Commerce

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence